Open AccessCXCR4 antagonist AMD3100 attenuates colonic damage in mice with experimental colitis
Author(s) -
Xianming Xia
Publication year - 2010
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v16.i23.2873
Subject(s) - colitis , proinflammatory cytokine , tumor necrosis factor alpha , cytokine , inflammation , chemokine , myeloperoxidase , chemistry , pathology , immunology , medicine
To investigate the effects of the chemokine stromal cell-derived factor-1 (CXCL12) receptor (CXCR4) antagonist AMD3100 on colonic inflammation and epithelial barrier in dextran sulfate sodium (DSS)-induced colitis in mice.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom